| scholarly article | Q13442814 |
| P2093 | author name string | Marc Coram | |
| David B Miklos | |||
| Shalini Pereira | |||
| Jane C Tan | |||
| Neeraja Kambham | |||
| Katherine Miller | |||
| F Carl Grumet | |||
| Persis P Wadia | |||
| Tamara Vayntrub | |||
| P2860 | cites work | Functional coherence of the human Y chromosome | Q24309552 |
| Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation | Q24537575 | ||
| Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission | Q24539030 | ||
| Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein | Q30464516 | ||
| Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: a retrospective analysis of registry data | Q31016677 | ||
| Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors | Q34312702 | ||
| The UTX gene escapes X inactivation in mice and humans | Q34460028 | ||
| Humoral theory of transplantation | Q35142603 | ||
| Y-antigen killing by T cells of women is restricted by HLA | Q40646077 | ||
| Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens | Q41747476 | ||
| C4d deposition in early renal allograft protocol biopsies | Q45022058 | ||
| Sex differences in sex chromosome gene expression in mouse brain | Q46717400 | ||
| Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation | Q46864244 | ||
| Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy | Q47588333 | ||
| Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants | Q47631013 | ||
| Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection | Q47869308 | ||
| Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome | Q47924867 | ||
| Plasma cell-rich acute renal allograft rejection | Q50108844 | ||
| Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation | Q50765005 | ||
| Comparison of C4d immunostaining methods in renal allograft biopsies. | Q53564483 | ||
| Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. | Q53662129 | ||
| Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. | Q53924174 | ||
| Incidence of C4d Stain in Protocol Biopsies from Renal Allografts: Results from a Multicenter Trial | Q58378349 | ||
| Microdroplet Assay of Human Serum Cytotoxins | Q59059757 | ||
| Diagnostic Value of C4d in Renal Allograft Biopsies in Different Clinical Settings: Absence of C4d in Grafts From Non-Heart-Beating Donors | Q62658655 | ||
| Alloimmunity to human H-Y | Q66706083 | ||
| The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies | Q73568094 | ||
| Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation | Q73874939 | ||
| C4d deposition in acute rejection: an independent long-term prognostic factor | Q77374161 | ||
| Skin | Q78248202 | ||
| Success rate and impact of HLA matching on kidney graft survival in highly immunized recipients. Collaborative Transplant Study | Q79311149 | ||
| Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy | Q81174772 | ||
| Antibodies against MICA antigens and kidney-transplant rejection | Q81357717 | ||
| Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies | Q81706493 | ||
| Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies | Q81778116 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 75-81 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | H-Y antibody development associates with acute rejection in female patients with male kidney transplants | |
| P478 | volume | 86 |
| Q38611402 | A systems-based approach to managing blood pressure in children following kidney transplantation |
| Q57293174 | Adipose-Derived Mesenchymal Stromal Cells Persist in Tissue-Engineered Vocal Fold Replacement in Rabbits |
| Q51071488 | Alemtuzumab induction in pediatric kidney transplantation |
| Q36818003 | Alemtuzumab induction in pediatric kidney transplantation. |
| Q54687845 | Alemtuzumab induction with tacrolimus monotherapy in 25 pediatric renal transplant recipients. |
| Q42226145 | Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience |
| Q49834046 | Applying Genomics in Heart Transplantation. |
| Q40168444 | Association of Sex with Risk of Kidney Graft Failure Differs by Age. |
| Q27009997 | Biologics in renal transplantation |
| Q48664001 | Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis |
| Q35244151 | Cardiac allograft vasculopathy: a donor or recipient induced pathology? |
| Q35235186 | Clinical impact of H-Y alloimmunity |
| Q37987565 | Current status of immunosuppressive agents for solid organ transplantation in children |
| Q36461741 | Decay accelerating factor is essential for successful corneal engraftment |
| Q33920683 | Donor-recipient gender and size mismatch affects graft success after kidney transplantation |
| Q36338297 | Donor-recipient sex mismatch in kidney transplantation |
| Q39363717 | Eight-year follow-up in pediatric living donor kidney recipients receiving alemtuzumab induction. |
| Q34792728 | Gender differences in liver donor quality are predictive of graft loss |
| Q30430243 | H-Y Antigen Incompatibility Not Associated with Adverse Immunologic Graft Outcomes: Deceased Donor Pair Analysis of the OPTN Database |
| Q34202524 | H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male : female ratio in subsequent live births |
| Q37330552 | H-Y incompatibility predicts short-term outcomes for kidney transplant recipients |
| Q33416779 | Human and murine kidneys show gender- and species-specific gene expression differences in response to injury |
| Q37086379 | Influence of donor-recipient sex mismatch on long-term survival of pancreatic grafts |
| Q90255868 | Non-HLA donor-recipient mismatches in kidney transplantation-A stone left unturned |
| Q35659332 | Recent advances in renal transplantation: antibody-mediated rejection takes center stage |
| Q35811966 | Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease |
| Q39409394 | Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation. |
| Q47558235 | Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. |
| Q90216900 | Sex matching does not impact the outcome after simultaneous pancreas-kidney transplantation |
| Q28748739 | Sex matters, but to what clinical avail? |
| Q38071546 | Steroid withdrawal in renal transplantation |
| Q47176453 | The impact of donor and recipient weight incompatibility on renal transplant outcomes |
| Q39175303 | Transplant genetics and genomics |
Search more.